Online Only Articles

Ibrutinib and idelalisib target B cell receptor- but not CXCL12/CXCR4-controlled integrin-mediated adhesion in Waldenström macroglobulinemia

Department of Pathology, Academic Medical Center, University of Amsterdam, The Netherlands
Department of Pathology, Academic Medical Center, University of Amsterdam, The Netherlands
Department of Pathology, Academic Medical Center, University of Amsterdam, The Netherlands
Deptartment of Hematology, Academic Medical Center, University of Amsterdam, The Netherlands;Lymphoma and Myeloma Center Amsterdam – LYMMCARE, The Netherlands
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA
Department of Pathology, Academic Medical Center, University of Amsterdam, The Netherlands;Lymphoma and Myeloma Center Amsterdam – LYMMCARE, The Netherlands
Department of Pathology, Academic Medical Center, University of Amsterdam, The Netherlands;Lymphoma and Myeloma Center Amsterdam – LYMMCARE, The Netherlands
Vol. 101 No. 3 (2016): March, 2016 https://doi.org/10.3324/haematol.2015.137265